Company: BNBX
Filing Date: 2025-01-10
Form Type: S-1/A
Source: 0001104659-25-002521
Chunk: 20

Company: BNB PLUS CORP.
Filing Date: 2025-01-10
Form: S-1/A
Chunk 20
---
 2025, the last reported sale price of our Common Stock was $0.20 per share. |

| Risk    
 Factors | See “Risk                                                                                                      
 Factors” beginning on page 8 and the other information included in this prospectus for a discussion of factors 
 you should carefully consider before investing in our securities.                                              |

The number of shares of our Common Stock to
be outstanding after this offering is based on the 55,188,523 shares of our Common Stock outstanding as of January 8, 2025, and excludes
the following:

| · | 107,243 shares                                                                            
 of Common Stock issuable upon exercise of options outstanding as of January 8, 2025, with 
 a weighted average exercise price of $173.09 per share;                                   |

<div align='center'>7</div>

| · | 91,791,191                                                                                     
 shares of Common Stock issuable upon exercise of warrants outstanding as of January 8, 2025,   
 with a weighted average exercise price of $0.44 per share (which includes an aggregate of      
 88,247,534 May 2024 Series A Warrants (reflecting the Price Reset Mechanism being              
 triggered by the Offering) and May 2024 Series B Warrants, of which 2,257,052 have             
 an alternative cashless exercise mechanism representing the right to receive 3 shares of       
 Common Stock for each warrant, which, if exercised, would result in 6,771,156 shares of Common 
 Stock being issued);                                                                           |

| · | 41,640,625                                                                                                                        
 shares of Common Stock issuable upon exercise of the Private Placement Warrants, whose exercise is subject to Warrant Stockholder 
 Approval, of which 20,312,500 have an alternative cashless exercise mechanism representing the right to receive 1 share of Common 
 Stock for each warrant; and                                                                                                       |

| · | 270,002                                                                                                              
 shares of Common Stock reserved for future grant or issuance as of January 8, 2025, under our equity incentive plan. |

Unless otherwise indicated, this prospectus reflects
and assumes no exercise of outstanding options and warrants.

<div align='center'>RISK FACTORS</div>

Investing in our securities involves a high degree of risk. In addition to the other information included or incorporated by reference in this prospectus, you should carefully consider the risks described below and in the section titled “Risk Factors” in our Annual Report on Form